PAH patients with cardiovascular disease risk had similar hospitalization and mortality rates as those without after a ...

Columnist Anna Jeter is delighted to find themes that are relevant to her life in the fictional narratives of writers and ...

Columnist Colleen Steele says that glimmers are like an antidote to some of the events that spark her caregiving anxiety.

Following the first sale of Yutrepia to treat certain types of PH, Liquidia has received $50 million under its financing ...

Adding Winrevair treatment significantly reduced the risk of clinical worsening in people with a recent PAH diagnosis, per a ...

A Phase 3 clinical trial testing the experimental daily oral treatment ralinepag in people with PAH has completed enrollment.

With patient enrollment now complete, topline results are expected early next year from a Phase 3 trial testing PAH treatment ...

Pulmonary hypertension (PH) is a rare but life-threatening lung disorder that damages the vessels responsible for transporting blood from the heart to the lungs, known as the pulmonary arteries. The ...

Pulmonary hypertension (PH) is a rare lung disease characterized by high blood pressure in the pulmonary arteries, which deliver blood from the heart to the lungs. The high pressure causes the heart ...

No description.Brittany Foster lives in Cranston, Rhode Island, and has a passion for teaching, writing, and advocating. She was a special educator for four years before beginning her work at Bionews ...

Opsumit (macitentan), an oral once-daily therapy, is approved to treat the symptoms and help slow the progression of PAH. It is also being investigated as a possible treatment for other types PH, ...

Living with a chronic disease like pulmonary hypertension (PH) can be challenging. It can affect a patient’s ability to accomplish daily tasks, as well as affect their quality of life. In addition to ...